Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > TSX Venture 50
View:
Post by retiredcf on Feb 24, 2021 1:12pm

TSX Venture 50

As can be seen, SVA made the list and was ranked #8 in the Clean Tech & Life Sciences sector. GLTA

https://v50.stocktrak.com
Comment by JonEcash on Feb 24, 2021 1:43pm
In terms of Canadian pharma companies, SVA is apparently 5th. I can see us taking over 1st in no time... Click link below: Investing News link J$
Comment by JonEcash on Feb 24, 2021 1:50pm
Just a self-edit. First place on the list might be a stretch but 2 and 3 are up for grabs. J$
Comment by 88STR8T on Feb 24, 2021 3:20pm
JonE, I believe IPA will be 1st place..... SVA could be 1st... but only with a buyout. Good Luck!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities